Cerulean Pharma Inc. Presents Clinical and Pre-Clinical Nanopharmaceutical Data at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that the Company’s senior executives presented at the 22nd EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics,” ongoing in Berlin, Germany.